| News
Syngenta grows strongly and stays true to Basel
18.06.2020
Syngenta AG, Adama and Sinochem are to be united under the umbrella of the new Syngenta Group. The group is headquartered in Basel and employs around 48,000 staff across over 100 countries.

Syngenta headquarter in Basel (img: Syngenta)
The agricultural group Syngenta is still staying true to its roots in Basel even after the takeover by Chemchina, as the newly founded Syngenta Group will be headquartered there. In addition to the former Syngenta AG, the group also comprises Adama from Israel and the agricultural business of Sinochem, which is based in China.
Syngenta Group started operating on Thursday according to a press release. The three companies are being connected to create a much larger group. Last year Syngenta, Adama and Sinochem achieved sales of 23 billion US dollars. In comparison, when Chemchina took on Syngenta in 2017 for 43 billion US dollars, the company had achieved sales of just under 13 billion dollars.
According to its own information, Syngenta Group is now the global market leader in crop protection, third place for seeds, and the market leader for fertilizers in China. Overall, it employs 48,000 staff in more than 100 countries.
Erik Fyrwald, former CEO of Syngenta AG, will head up the new group as CEO. He says: “I am pleased that our new organization is ready to bring the diversity and expertise of our teams to deliver the broadest range of sustainable and competitive products.” He goes on to say that the individual business units will be “enhanced” by the collaboration within the group.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
KUORI developing biodegradable plastics
The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...
Read MoreCell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read MoreBLKB expanding support for startups
BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...
Read MoreCombatting the rise of antimicrobial resistance
Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...
Read MoreAMR Action Fund invests in new antibiotics developed by BioVersys
The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...
Read MoreInvestors give Resistell 8.5 million Swiss francs
Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...
Read More